Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Review
  • Published:

MicroRNAs and the hallmarks of cancer

Oncogene volume 25, pages 6170–6175 (2006)Cite this article

Abstract

It has become clear that particular microRNAs (miRNAs) function either as tumour suppressors or oncogenes, whose loss or overexpression, respectively, has diagnostic and prognostic significance. In several cases, miRNAs have been shown to affect target genes that are involved in the control of cell proliferation and apoptosis. However, malignant tumours display additional traits beyond the acquisition of enhanced growth potential and decreased cell death. Malignant disease is associated with altered tumour–host interactions leading to sustained angiogenesis and the ability to invade and metastasize. It is possible that miRNAs may act as master regulators of these aspects of tumour biology. Bioinformatic analysis of putative miRNA binding sites has indicated several novel potential gene targets of cancer-associated miRNAs that function in aspects of cell adhesion, neovascularization and tissue invasion. Among others, we speculate that miRNAs may find new roles in the regulation of E-cadherin, integrin αvβ3, hypoxia-inducible factor-1α, syndecan-1, lysyl oxidase, adamalysin metalloproteinase-17, tissue inhibitors of metalloproteinase-3, c-Met and CXCR-4 that underpin the tissue architectural changes associated with malignancy.

This is a preview of subscription content, access via your institution

Access options

Buy this article

  • Purchase on Springer Link
  • Instant access to full article PDF
Buy now

Prices may be subject to local taxes which are calculated during checkout

Similar content being viewed by others

References

  • Ahonen M, Poukkula M, Baker A, Kashiwagi M, Hideaki N, Eriksson JE et al. (2003). Oncogene 22: 2121–2134.

  • Baker A, Edwards DR, Murphy G . (2002). J Cell Sci 115: 3719–3727.

  • Bergers G, Benjamin LE . (2003). Nat Rev Cancer 3: 401–410.

  • Blobel CP . (2005). Nat Rev Mol Cell Biol 6: 32–43.

  • Cavallaro U, Christofori G . (2004). Nat Rev Cancer 4: 118–132.

  • Chan JA, Krichevsky AM, Kosik KS . (2005). Cancer Res 65: 6029–6033.

  • Cruz-Munoz W, Sanchez OH, Di Grappa M, English JL, Hill RP, Khokha R . (2006). Oncogene advance online publication 15 May 2006; doi:10.1038/sj.onc.1209663.

  • Egeblad M, Werb Z . (2002). Nat Rev Cancer 2: 161–174.

  • Endo K, Takino T, Miyamori H, Kinsen H, Yoshizaki T, Furukawa M et al. (2003). J Biol Chem 278: 40764–40770.

  • Erler JT, Bennewith KL, Nicolau M, Dornhöfer N, Kong C, Le Q-T et al. (2006). Nature 440: 1222–1226.

  • Esquela-Kerscher A, Slack FJ . (2006). Nat Rev Cancer 6: 259–269.

  • Esteller M, Corn PG, Baylin S, Herman JG . (2001). Cancer Res 61: 3225–3229.

  • Fidler IJ . (2003). Nat Rev Cancer 3: 453–458.

  • Hanahan D, Weinberg RA . (2000). Cell 100: 57–70.

  • Harris AL . (2002). Nat Rev 2: 38–47.

  • He H, Jazdzewski K, Li W, Liyanarachchi S, Nagy R, Volinia S et al. (2005). Proc Natl Acad Sci USA 102: 19075–19080.

  • Hirohashi S . (1998). Am J Pathol 153: 333–339.

  • Hood JD, Cheresh DA . (2002). Nat Rev Cancer 2: 91–100.

  • Hwang H-W, Mendell JT . (2006). Br J Cancer 94: 776–780.

  • Iorio MV, Ferracin M, Liu C-G, Veronese A, Spizzo R, Sabbioni S et al. (2005). Cancer Res 65: 7065–7070.

  • Johnson SM, Grosshans H, Shingara J, Byrom M, Jarvis R, Cheng A et al. (2005). Cell 120: 635–647.

  • Krutzfeldt J, Rajewsky N, Braich R, Rajeev KG, Tuschl T, Manoharan M et al. (2005). Nature 438: 685–689.

  • Lagos-Quintana M, Rauhut R, Yalcin A, Meyer J, Lendeckel W, Tuschl T . (2002). Curr Biol 12: 735–739.

  • Lewis BP, Burge CB, Bartel DP . (2005). Cell 120: 15–20.

  • Lim LP, Lau NC, Garrett-Engele P, Grimson A, Schelter JM, Castle J et al. (2005). Nature 433: 769–773.

  • Lu C, Kerbel RS . (1993). J Cell Biol 120: 1281–1288.

  • Lu J, Getz G, Miska EA, Alvarez-Saavedra E, Lamb J, Peck D et al. (2005). Nature 435: 834–838.

  • Liu MC, Choong DY, Hooi CS, Williams LH, Campbell IG . (2006). Cancer Lett doi: 10.1016/j.canlet.2006.03.024.

  • Mohammed FF, Smookler DS, Taylor SEM, Fingleton B, Kassiri Z, Sanchez OH et al. (2004). Nat Genet 36: 969–977.

  • Mueller MM, Fusenig NE . (2004). Nat Rev Cancer 4: 838–849.

  • Müller A, Homey B, Soto H, Ge N, Catron D, Buchanan ME et al. (2001). Nature 410: 40–56.

  • O'Donnell KA, Wentzel EA, Zeller KI, Dang CV, Mendell JT . (2005). Nature 435: 839–843.

  • Oh J, Takahashi R, Kondo S, Mizoguchi A, Adachi E, Sasahara RM et al. (2001). Cell 107: 789–800.

  • Qi JH, Ebrahem Q, Moore N, Murphy G, Claesson-Welsh L, Bond M et al. (2003). Nat Med 9: 407–415.

  • Thiery JP . (2002). Nat Rev Cancer 2: 442–454.

  • Volinia S, Calin GA, Liu C-G, Ambs S, Cimmino A, Petrocca F et al. (2006). PNAS 103: 2257–2261.

  • Voorhoeve PM, le Sage C, Schrier M, Gillis AJM, Stoop H, Nagel R et al. (2006). Cell 124: 1169–1181.

  • Yanaihara N, Caplen N, Bowman E, Seike M, Kumamoto K, Yi M et al. (2006). Cancer Cell 9: 189–198.

  • Yang AD, Camp ER, Fan F, Shen L, Gray MJ, Liu W et al. (2006). Cancer Res 66: 46–51.

  • Zhang L, Huang J, Yang N, Greshock J, Megraw MS, Giannakakis A et al. (2006). Proc Natl Acad Sci USA 103: 9136–9141.

Download references

Acknowledgements

This work is supported by grants from the Breast Cancer Campaign, Big C Appeal and the Cancerdegradome project LSHC-CT-2003-503297 from the European Union Framework Programme 6.

Author information

Authors and Affiliations

  1. School of Biological Sciences, University of East Anglia, Norwich, UK

    T Dalmay & D R Edwards

Authors
  1. T Dalmay
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. D R Edwards
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding authors

Correspondence to T Dalmay or D R Edwards.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Dalmay, T., Edwards, D. MicroRNAs and the hallmarks of cancer. Oncogene 25, 6170–6175 (2006). https://doi.org/10.1038/sj.onc.1209911

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/sj.onc.1209911

Keywords

This article is cited by

Search

Advanced search

Quick links